Liver failure in human immunodeficiency virus - Hepatitis C virus coinfection treated with sofosbuvir, ledipasvir and antiretroviral therapy

J Hepatol. 2016 Mar;64(3):752-3. doi: 10.1016/j.jhep.2015.10.033. Epub 2015 Dec 9.

Authors

Alvaro Marchan-Lopez¹, Lourdes Dominguez-Dominguez², Pablo Kessler-Saiz², Miguel Eduardo Jarrin-Estupiñan²

Affiliations

¹ Department of Internal Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain. Electronic address: [email protected].
² Department of Internal Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain.

PMID: 26682727
DOI: 10.1016/j.jhep.2015.10.033

No abstract available

Publication types

Letter
Comment

MeSH terms

Antiviral Agents / therapeutic use
Coinfection / drug therapy
HIV Infections / drug therapy
Hepacivirus*
Hepatitis C / drug therapy
Hepatitis C, Chronic / drug therapy
Humans
Liver Failure / drug therapy
Sofosbuvir*
Uridine Monophosphate / administration & dosage

Substances

Antiviral Agents
Uridine Monophosphate
Sofosbuvir